Join us today for the FDA’s Virtual Town Hall for Test Developers of SARS-CoV-2

From 12:05 p.m.-1 p.m. ET [new time], the FDA will answer questions about the development and validation of tests for SARS-CoV-2.

If your email program has trouble displaying this email, view as a webpage. Reminder: Virtual Town Hall for Test Developers of SARS-CoV-2 Today from 12:05 p.m.-1 p.m. ET [new time], the U.S. Food and Drug Administration (FDA) will host a Virtual Town Hall for test developers of SARS-CoV-2. During this Town Hall, the FDA will answer technical questions about the development and validation of tests for SARS-CoV-2. Panelists include: Timothy Stenzel, M.D., Ph.D., Director of the Office of In Vitro Diagnostics Toby Lowe, Associate Director for Regulatory Programs, Office of In Vitro Diagnostics Kristian Roth, Ph.D., Deputy Director of the Division of Microbiology Devices, Office of In Vitro Diagnostics View the Town Hall Details Previous Virtual Town Halls Recordings, printable slides, and transcripts from previous Town Halls are available on the FDA website. Questions? For general questions, including about this Town Hall, contact Division of Industry and Consumer Education. For specific questions about COVID-19 diagnostic development, contact CDRH-EUA-Templates@fda.hhs.gov.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA